Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled study

AIM: This study was carried out in patients with neuropathic pain in order to assess the analgesic effects and changes in protein biomarkers after the administration of methylene blue (MB), a diaminophenothiazine with antioxidant and anti-inflammatory properties, and with inhibitory effects on nitri...

Descripción completa

Detalles Bibliográficos
Autores principales: Miclescu, Adriana A, Svahn, Martin, Gordh, Torsten E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509536/
https://www.ncbi.nlm.nih.gov/pubmed/26213475
http://dx.doi.org/10.2147/JPR.S84685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509536/
https://www.ncbi.nlm.nih.gov/pubmed/26213475
http://dx.doi.org/10.2147/JPR.S84685

Ejemplares similares